News Briefs
America’s National Cancer Institute (NCI) has acknowledged oleocanthal as a potential nutraceutical for breast cancer and awarded $399,999 to the company, Oleolive, for the development of the phenolic compound as a functional food to prevent breast cancer.
The funds will be used to research the preventative and therapeutic benefits of oleocanthal in triple negative breast cancer (TNBC) recurrence. Around 50,000 women in the United States are diagnosed with TNBC annually.
See Also:Health NewsA new, safe and effective recurrence inhibitor is urgently needed as the current outlook for TNBC patients is bleak due to high recurrence rates, poor overall survival rates and ineffective available treatments.
Oleocanthal experts Khalid El Sayed and Amal Kaddoumi, who are the company’s chief scientists and researchers at the University of Louisiana-Monroe, co-authored a 2017 study which revealed that oleocanthal was effective in preventing cancer and Alzheimer’s disease in mice and had the potential to become an effective dietary supplement for reducing the risk of developing both conditions.
El Sayed told Olive Oil Times the nutraceutical will be made available to patients once the team has established the desired potency and efficacy of the oleocanthal formulation for preventing TNBC recurrence. He said that further funding would be sought to prepare the formulation for clinical trials on humans.
“[I would] certainly recommend consumption of high-quality extra virgin olive oil daily for not only breast cancer survivors and patients but also for normal healthy people to maintain a condition of well-being based on the significant positive health outcomes documented by several clinical trials and epidemiological studies,” he said.
His recommendation was an average daily consumption of around 20 to 50 milliliters of olive oil per day, depending on an individual’s health and the quality of olive oil consumed. He advised new consumers of olive oil to start with smaller amounts (five to 10 milliliters) and gradually increase the daily dose over time.
More articles on: breast cancer, cancer prevention, oleocanthal
Jul. 24, 2024
New Process Increases Sustainability, Phenolic Profile of Olive Leaf Extracts
A novel approach does not use harmful chemicals and creates an extract with potential uses in olive oil production and food packaging.
May. 16, 2024
Daily Olive Oil Consumption Linked to Lower Dementia Death Risk, Study Finds
Harvard researchers found that daily consumption of at least seven grams of olive oil was associated with a 28 percent lower risk of dementia-related death.
Oct. 26, 2023
Research Shows the Role of Polyphenols in Inhibiting Cancer Metastasis
Spanish scientists investigated the role of oleocanthal and oleacein in modulating angiogenesis, which is directly related to the progression of different types of tumors.
Oct. 12, 2023
Researchers Identify Three Olive Varieties Resistant to Pervasive Fungus
Three cross breeds of Frantoio, Koroneiki and Arbosana olives resisted Verticillium dahlia in a controlled environment.
Nov. 14, 2023
Mediterranean Diet Linked to Improved Outcomes in Liver Disease Patients
Following the Mediterranean diet for one year improved the symptoms of non-alcoholic fatty liver disease in obese patients over the age of 60.
Apr. 9, 2024
The Role of Monounsaturated Fatty Acids in Olive Oil's Health Benefits
Oleic acid, classified as a monounsaturated fatty acid (MUFA), has been extensively studied by scientists over the last decades, consistently demonstrating many positive effects on human health.
Feb. 20, 2024
New Research Rekindles Debate on Nutri-Score’s Effectiveness
The OECD found Nutri-Score could save money on healthcare. Dutch researchers questioned the integrity of studies supporting the labeling system.
Apr. 3, 2024
Uruguay to Host Conference on Olive Oil Sector Research, Innovation
Scientists, producers and officials will meet in Uruguay in November to discuss the challenges and opportunities for South America’s olive oil sector.